Compare
5 stocks, side by sideRelative performance · rebased to 100
IBRXTGTXPTGXIMVTPCVX
| IBRXImmunityBio, Inc. | TGTXTG Therapeutics, Inc. | PTGXProtagonist Therapeutics, Inc. | IMVTImmunovant, Inc. | PCVXVaxcyte, Inc. | |
|---|---|---|---|---|---|
| Smart Score | 10/10 | 9/10 | 9/10 | 5/10 | 3/10 |
| Price | $8.30 | $55.68 | $145.88 | $39.52 | $60.36 |
| 1 month | +14% | +12% | -0.30% | -0.64% | +2.4% |
| 1 year | +242% | +101% | +160% | +159% | +88% |
| 5 year | -26% | +150% | +204% | +387% | +137% |
| P/E (TTM) | -9.8 | 19.5 | -80.6 | -14.3 | -8.8 |
| P/E vs sector | - | -35% | - | - | - |
| Market cap | $8.2B | $8.2B | $7.9B | $7.9B | $7.8B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.